martes, 11 de abril de 2023

Predicting response to enzalutamide and abiraterone in metastatic prostate cancer using whole-omics machine learning - PubMed

Predicting response to enzalutamide and abiraterone in metastatic prostate cancer using whole-omics machine learning - PubMed
Publicado por en

No hay comentarios:

Publicar un comentario

Suscribirse a: Enviar comentarios (Atom)